Genscript Biotech (HKSE:01548) EPS (Basic): HK$-1.91 (TTM As of Dec. 2025)


HKSE:01548 Genscript Biotech Corp HKSE:01548
73 GF Score
Price HK$12.03
GF Value HK$21.18
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Genscript Biotech EPS (Basic)?

Genscript Biotech HKSE:01548 -0.74% 73 EPS (Basic) is HK$-1.91 as of Dec. 2025. GuruFocus rates HKSE:01548 with a GF Score™ of 73/100 and a GF Value™ of HK$21.18 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Genscript Biotech's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was HK$-1.82. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-1.91.

Genscript Biotech's EPS (Diluted) for the six months ended in Dec. 2025 was HK$-1.82. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-1.99.

Genscript Biotech's EPS without NRI for the six months ended in Dec. 2025 was HK$-0.68. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was -0.87.

During the past 3 years, the average EPS without NRI Growth Rate was 0.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 12 years, Genscript Biotech's highest 3-Year average EPS without NRI Growth Rate was 56.50% per year. The lowest was -25.30% per year. And the median was 8.30% per year.

Genscript Biotech  (HKSE:01548) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Genscript Biotech EPS (Basic) Related Terms

Genscript Biotech EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Genscript Biotech's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genscript Biotech EPS (Basic) Chart

Genscript Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.38 -0.84 -0.35 10.85 -1.91

Genscript Biotech Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.65 11.50 -0.09 -1.82
HKSE:01548
73GF Score
Genscript Biotech Corp HKSE:01548
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genscript Biotech EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Genscript Biotech's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-4145.844-0)/2167.322
=-1.91

Genscript Biotech's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-3947.729-0)/2179.792
=-1.81

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-1.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of HK$-1.91 mean?
Genscript Biotech (HKSE:01548) has a EPS (Basic) of HK$-1.91 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Genscript Biotech and its competitors.
Is Genscript Biotech's EPS (Basic) too high?
Genscript Biotech's current EPS (Basic) is HK$-1.91. Overall, Genscript Biotech has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genscript Biotech's EPS (Basic) compare to VRTX and REGN?
Genscript Biotech's EPS (Basic) of HK$-1.91 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Genscript Biotech and its competitors. Genscript Biotech's current EPS (Basic) is HK$-1.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genscript Biotech stock overvalued right now?
Based on GuruFocus' analysis, Genscript Biotech (HKSE:01548) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$21.18, compared to a current price of HK$12.03 — trading 43.2% below its estimated fair value. The current EPS (Basic) is HK$-1.91. Genscript Biotech's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Genscript Biotech (HKSE:01548), the current EPS (Basic) is HK$-1.91 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genscript Biotech (HKSE:01548) Overvalued in 2026?

Based on GuruFocus' analysis, Genscript Biotech stock appears to be undervalued. The current stock price of HK$12.03 is trading 43.2% below its estimated GF Value™ of HK$21.18. GuruFocus considers Genscript Biotech to be Significantly Undervalued.

Key valuation signals for HKSE:01548:

  • EPS (Basic): HK$-1.91
  • GF Value™: HK$21.18 vs. price of HK$12.03 (43.2% below fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the HKSE:01548 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genscript Biotech Business Description

Other Exchanges GNNSF:USAG51:Germany
Address 860 Centennial Avenue, Piscataway, NJ, USA, 08854
GenScript Biotech Corp is an investment holding company engaged in the manufacture and sale of life science research products and services, including life science services and products, biologics development services, and industrial synthetic biology products. Its segments include life science services and products, which generate maximum revenue and provide research services and products; biologics development services, which support the development of therapeutic antibodies and CGT products; industrial synthetic biology, which provides enzyme development and production using engineered microbial strains; and the operation unit, which provides shared services. It operates in Mainland China, which generates maximum revenue, U.S., Europe, and the Asia Pacific excluding Mainland China.
73GF Score

Get the complete analysis for HKSE:01548

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$12.03
Price
HK$21.18
GF Value